For a better experience, click the Compatibility Mode icon above to turn off Compatibility Mode, which is only for viewing older websites.

Raymond Talucci

Raymond Talucci, MD

Professor


Department: Surgery

Specialties: General Surgery, Trauma and Surgical Critical Care

Education

  • MD - University of Maryland School of Medicine (1977)
  • BA in Biology - St. Anselms College (1972)

Awards & Honors

  • NIH Research Service Award, University of Washington School of Medicine, Department of Surgery

Dr. Talucci is currently the trauma director at St. Mary Medical Center.

Clinical Services

Critical care, Trauma

Internships

  • Charity Hospital of Louisiana Tulane Division, New Orleans (1978)

Residencies

  • Surgery - Tulane University and Affiliated Hospitals (1982)

Fellowships

  • University of Washington School of Medicine (1984)

Dr. Talucci has been a professor in the Department of Surgery at Drexel University College of Medicine since 2001. He also serves as trauma director at St. Mary Medical Center.

Research

Selected Research

"Prophylactic Use of Diflucan in patients with overwhelming Sepsis"
Supported by Educational Grant Pfizer Corporation, 1996

"Levofloxacin: Complicated Intraabdominal Infection Study"
Hoechst-Roussel Pharmaceuticals, Inc. Protocol No.: 301, 1994

"Functional Capacity Index Validation Study"
Johns Hopkins School of Public Health, 1994

"The Development of the New Jersey Component of the Atlantic Council Registry"
The Atlantic Emergency Medical Services Council in accord with the Department of Transportation Grant Project No. DTNH22-88-Z-07386, 1990

"Patient Controlled Analgesia vs. Conventional Pain Therapy"
Becton, Dickinson & Co., A. Cernainu, Principal Investigator, 1988

"Multicenter Trial to determine the Safety & Efficiency of Antiendotoxin Antibody XMEN-OE5 in the Treatment of Patients with suspected gram-negative bacteremia or endotoxemia"
XOMA Corporation, Reference Ind:BB-2309, Protocol No.: 8l612-P2B, 1987

"Use of Intravenous Nizatidine to Control Gastric Acid Secretion in the Intensive Care Unit Patient"
Eli Lilly Company B5Q-MC-NBAQ LY 139037 Nizatidine Ind. 18975 NDA-l9-509, 1986

* This physician's clinical practice is independent of Drexel University.